1
|
Breteler MM: Vascular risk factors for
Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging.
21:153–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhu CW, Scarmeas N, Torgan R, Albert M,
Brandt J, Blacker D, Sano M and Stern Y: Longitudinal study of
effects of patient characteristics on direct costs in Alzheimer
disease. Neurology. 67:998–1005. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gorelick PB: Risk factors for vascular
dementia and Alzheimer disease. Stroke. 35 11 Suppl 1:S2620–S2622.
2004. View Article : Google Scholar
|
4
|
Viticchi G, Falsetti L, Vernieri F,
Altamura C, Bartolini M, Luzzi S, Provinciali L and Silvestrini M:
Vascular predictors of cognitive decline in patients with mild
cognitive impairment. Neurobiol Aging. 33:1127.e1–9. 2012.
View Article : Google Scholar
|
5
|
Aguero-Torres H, Kivipelto M and von
Strauss E: Rethinking the dementia diagnosis in a population-based
study: What is Alzheimer's disease and what is vascular dementia? A
study from the Kungsholmen project. Dement Geriatr Cogn Disord.
22:244–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Grammas P, Yamada M and Zlokovic B: The
cerebromicrovasculature: A key player in the pathogenesis of
Alzheimer's disease. J Alzheimers Dis. 4:217–123. 2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Humpel C and Marksteiner J:
Cerebrovascular damage as a cause for Alzheimer's disease. Curr
Neurovasc Res. 2:341–347. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li J, Zhang M, Xu ZQ, Gao CY, Fang CQ,
Deng J, Yan JC, Wang YJ and Zhou HD: Vascular risk aggravates the p
rogression of Alzheimer's disease in a Chinese cohort. J Alzheimers
Dis. 20:491–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Luzzi S, Vella L, Bartolini M, Provinciali
L and Silvestrini M: Atherosclerosis in the evolution of
Alzheimer's disease: Can treatment reduce cognitive decline? J
Alzheimers Dis. 20:893–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
López-Olóriz J, López-Cancio E, Arenillas
JF, Hernández M, Jiménez M, Dorado L, Barrios M, Soriano-Raya JJ,
Miralbell J, Cáceres C, et al: Asymptomatic cervicocerebral
atherosclerosis, intracranial vascular resistance and cognition:
The AsIA-neuropsychology study. Atherosclerosis. 230:330–335. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Lorenz MW, Markus HS, Bots ML, Rosvall M
and Sitzer M: Prediction of clinical cardiovascular events with
carotid intima-media thickness: A systematic review and
meta-analysis. Circulation. 30:459–467. 2007. View Article : Google Scholar
|
12
|
Johnston SC, O'Meara ES, Manolio TA,
Lefkowitz D, O'Leary DH, Goldstein S, Carlson MC, Fried LP and
Longstreth WT Jr: Cognitive impairment and decline are associated
with carotid artery disease in patients without clinically evident
cerebrovascular disease. Ann Intern Med. 140:237–247. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Komulainen P, Kivipelto M, Lakka TA,
Hassinen M, Helkala EL, Patja K, Nissinen A and Rauramaa R: Carotid
intima-media thickness and cognitive function in elderly women: A
population-based study. Neuroepidemiology. 28:207–213. 2007.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Muller M, Grobbee DE, Aleman A, Bots M and
van der Schouw YT: Cardiovascular disease and cognitive performance
in middle aged and elderly men. Atherosclerosis. 190:143–149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Silvestrini M, Gobbi B, Pasqualetti P,
Bartolini M, Baruffaldi R, Lanciotti C, Cerqua R, Altamura C,
Provinciali L and Vernieri F: Carotid atherosclerosis and cognitive
decline in patients with Alzheimer's disease. Neurobiol Aging.
30:1177–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Urbanova B, Tomek A, Mikulik R, Magerova
H, Horinek D and Hort J: Neurosonological examination: A
non-invasive approach for the detection of cerebrovascular
impairment in AD. Front Behav Neurosci. 8:42014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tachibana H, Washida K, Kowa H, Kanda F
and Toda T: Vascular function in Alzheimer's disease and vascular
dementia. Am J Alzheimers Dis Other Demen. 31:437–442. 2016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Heinzel S, Liepelt-Scarfone I, Roeben B,
Nasi-Kordhishti I, Suenkel U, Wurster I, Brockmann K, Fritsche A,
Niebler R, Metzger FG, et al: A neurodegenerative vascular burden
index and the impact on cognition. Front Aging Neurosci.
9:1612014.
|
19
|
McKhann G, Drachman D, Folstein M, Katzman
R, Price D and Stadlan EM: Clinical diagnosis of Alzheimer's
disease: Report of the NINCDS-ADRDA work group under the auspices
of department of health and human services task force on
Alzheimer's disease. Neurology. 34:939–944. 1984. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hughes CP, Berg L, Danziger WL, Coben LA
and Martin RL: A new clinical scale for staging of dementia. Br J
Psychiatry. 140:566–572. 1982. View Article : Google Scholar : PubMed/NCBI
|
21
|
Román GC, Tatemichi TK, Erkinjuntti T,
Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A,
Hofman A, et al: Vascular dementia: Diagnostic criteria for
research studies. Report of the NINDS-AIREN International Workshop.
Neurology. 43:250–260. 1993. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hachinski VC, Iliff LD, Zilhka E, Du
Boulay GH, McAllister VL, Marshall J, Russell RW and Symon L:
Cerebral blood flow in dementia. Arch Neurol. 32:632–637. 1975.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Wahlund LO, Barkhof F, Fazekas F, Bronge
L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, et
al: A new rating scale for age-related white matter changes
applicable to MRI and CT. Stroke. 32:1318–1322. 2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhou HD, Wang JY, Li J, Deng J, Gao C and
Chen M: Study on frequency and predictors of dementia after
ischemic stroke: The Chongqing stroke study. J Neurol. 251:421–427.
2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Rosen WG, Mohs RC and Davis KL: A new
rating scale for Alzheimer's disease. Am J Psychiatry.
141:1356–1364. 1984. View Article : Google Scholar : PubMed/NCBI
|
26
|
Fuld PA, Masur DM, Blau AD, Crystal H and
Aronson MK: Object-memory evaluation for prospective detection of
dementia in normal functioning elderly: Predictive and normative
data. J Clin Exp Neuropsychol. 12:520–528. 1990. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang M: Prevalence study on dementia and
Alzheimer disease. Zhonghua Yi Xue Za Zhi. 70424–428. (430)1990.(In
Chinese). PubMed/NCBI
|
28
|
Welsh KA, Butters N, Hughes JP, Mohs RC
and Heyman A: Detection and staging of dementia in Alzheimer's
disease. Use of the neuropsychological measures developed for the
consortium to establish a registry for Alzheimer's disease. Arch
Neurol. 49:448–452. 1992. View Article : Google Scholar : PubMed/NCBI
|
29
|
Katz S, Downs TD, Cash HR and Grotz RC:
Progress in development of the index of ADL. Gerontologist.
10:20–30. 1970. View Article : Google Scholar : PubMed/NCBI
|
30
|
Touboul PJ, Prati P, Scarabin PY, Adrai V,
Thibout E and Ducimetière P: Use of monitoring software to improve
the measurement of carotid wall thickness by B-mode imaging. J
Hypertens. 10 Suppl:S37–S41. 1992. View Article : Google Scholar
|
31
|
Dubey AK, Varma Y, Dubey S, Singh G, Dubey
AK, Sharma V and Grade S: PW195 lipid profile and carotid intimal
medial thickness in different stages of chronic kidney disease.
Global Heart. 9:e2972014. View Article : Google Scholar
|
32
|
Xiang J, Zhang T, Yang QW, Liu J, Chen Y,
Cui M, Yin ZG, Li L, Wang YJ, Li J and Zhou HD: Carotid artery
atherosclerosis is correlated with cognitive impairment in an
elderly urban Chinese non-stroke population. J Clin Neurosci.
20:1571–1575. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Firebaugh G, Warner C and Massoglia M:
Fixed effects, random effects and hybrid models for causal
analysisMorgan SL: Handbook of Causal Analysis for Social Research.
Springer Science+Business Media Dordrecht; pp. 113–132. 2013,
View Article : Google Scholar
|
34
|
Schneider JA, Wilson RS, Bienias JL, Evans
DA and Bennett DA: Cerebral infarctions and the likelihood of
dementia from Alzheimer disease pathology. Neurology. 62:1148–1155.
2004. View Article : Google Scholar : PubMed/NCBI
|
35
|
Snowdon DA, Greiner LH, Mortimer JA, Riley
KP, Greiner PA and Markesbery WR: Brain infarction and the clinical
expression of Alzheimer disease: The Nun study. JAMA. 227:813–817.
1997. View Article : Google Scholar
|
36
|
Ruitenberg A, den Heijer T, Bakker SL, van
Swieten JC, Koudstaal PJ, Hofman A and Breteler MM: Cerebral
hypoperfusion and clinical onset of dementia: The Rotterdam Study.
Ann Neurol. 57:789–794. 2005. View Article : Google Scholar : PubMed/NCBI
|
37
|
Toledo JB, Arnold SE, Raible K,
Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA and
Trojanowski JQ: Contribution of cerebrovascular disease in autopsy
confirmed neurodegenerative disease cases in the National
Alzheimer's Coordinating Centre. Brain. 136:2697–2706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Stampfer MJ: Cardiovascular disease and
Alzheimer's disease: Common links. J Intern Med. 260:211–223. 2006.
View Article : Google Scholar : PubMed/NCBI
|
39
|
de la Torre JC: Is Alzheimer's disease a
neurodegenerative or a vascular disorder? Data, dogma, and
dialectics. Lancet Neurol. 3:184–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
40
|
Lathe R, Sapronova A and Kotelevtsev Y:
Atherosclerosis and Alzheimer-diseases with a common cause?
Inflammation, oxysterols, vasculature. BMC Geriatr. 21:14–36.
2014.
|
41
|
Devereux RB and Alderman MH: Role of
preclinical cardiovascular disease in the evolution from risk
factor exposure to development of morbid events. Circulation.
88:1444–1455. 1993. View Article : Google Scholar : PubMed/NCBI
|
42
|
Bots ML, van Swieten JC, Breteler MM, de
Jong PT, van Gijn J, Hofman A and Grobbee DE: Cerebral white matter
lesions and atherosclerosis in the Rotterdam study. Lancet.
341:1232–1237. 1993. View Article : Google Scholar : PubMed/NCBI
|
43
|
Viswanathan A, Rocca WA and Tzourio C:
Vascular risk factors and dementia. How to move forward? Neurology.
72:368–374. 2009.PubMed/NCBI
|
44
|
Deschaintre Y, Richard F, Leys D and
Pasquier F: Treatment of vascular risk factors is associated with
slower decline in Alzheimer disease. Neurology. 73:674–680. 2009.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Morris JC, Storandt M, Miller JP, McKeel
DW, Price JL, Rubin EH and Berg L: Mild cognitive impairment
represents early-stage Alzheimer disease. Arch Neurol. 58:397–405.
2001. View Article : Google Scholar : PubMed/NCBI
|
46
|
Silvestrini M, Vernieri F, Pasqualetti P,
Matteis M, Passarelli F, Troisi E and Caltaqirone C: Impaired
cerebral vasoreactivity and risk of stroke in patients with
asymptomatic carotid artery stenosis. JAMA. 283:2122–2127. 2000.
View Article : Google Scholar : PubMed/NCBI
|